Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04961112 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits
A NA study, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT04961112: Completed NA study, sponsored by Tufts University.
NCT04961112 is a NA study that has completed, run by Tufts University. The registered enrollment target is 124 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04961112, a NA study, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
This study investigates the potential of cranial electrotherapy stimulation to mitigate anxiety induced cognitive deficits
Primary Outcome
Switch cost (mean switch reaction time- mean stay reaction time)
Interventions
- DEVICE Cranial Electrotherapy Stimulation
- DEVICE Sham Cranial Electrotherapy Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2021-09-06 |
| Est. Completion | 2025-04-07 |
| Phase | NA |
What the finished NCT04961112 record still lists
NCT04961112 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Cranial Electrotherapy Stimulation is the first listed.
NCT04961112 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04961112 about?
NCT04961112 is a clinical study titled "Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits". This study investigates the potential of cranial electrotherapy stimulation to mitigate anxiety induced cognitive deficits
What is the current status of trial NCT04961112?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2021-09-06. Estimated completion is 2025-04-07.
What interventions are being tested in trial NCT04961112?
The interventions under investigation include: Cranial Electrotherapy Stimulation (DEVICE), Sham Cranial Electrotherapy Stimulation (DEVICE).
Who is sponsoring clinical trial NCT04961112?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04961112's enrollment target sits among peer trials
124 758th of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI